Low dose cyclosporine in early rheumatoid arthritis : Effective and safe after two years of therapy when compared with chloroquineVAN DEN BORNE, B. E. E. M; LANDEWE, R. B. M; GOEI THE, H. S et al.Scandinavian journal of rheumatology. 1996, Vol 25, Num 5, pp 307-316, issn 0300-9742Article

No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritisVAN DEN BORNE, B. E. E. M; LANDEWE, R. B. M; MOENS, H. J. B et al.Arthritis and rheumatism. 1998, Vol 41, Num 11, pp 1930-1937, issn 0004-3591Article

Antimalarial drug induced decrease in creatinine clearanceLANDEWE, R. B. M; VERGOUWEN, M. S. C; GOEI THE, H. S et al.Journal of rheumatology. 1995, Vol 22, Num 1, pp 34-37, issn 0315-162XArticle

Cyclosporine in common clinical practice : an estimation of the benefit/risk ratio in patients with rheumatoid arthritisLANDEWE, R. B. M; GOEI THE, H. S; VAN RIJTHOVEN, A. W. A. M et al.Journal of rheumatology. 1994, Vol 21, Num 9, pp 1631-1636, issn 0315-162XArticle

Cyclosporin A therapy in rheumatoid arthritis : only strict application of the guidelines for safe use can prevent irreversible renal function lossVAN DEN BORNE, B. E. E. M; LANDEWE, R. B. M; GOEI THE, H. S et al.Rheumatology (Oxford. Print). 1999, Vol 38, Num 3, pp 254-259, issn 1462-0324Article

Combination therapy in recent onset rheumatoid arthritis : A randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquineVAN DEN BORNE, B. E. E. M; LANDEWE, R. B. M; GOEI THE, H. S et al.Journal of rheumatology. 1998, Vol 25, Num 8, pp 1493-1498, issn 0315-162XArticle

Longterm low dose cyclosporine in patients with rheumatoid arthritis : renal function loss without structural nephropathyLANDEWE, R. B. M; DIJKMANS, B. A. C; VAN DER WOUDE, F. J et al.Journal of rheumatology. 1996, Vol 23, Num 1, pp 61-64, issn 0315-162XArticle

The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destructionGEUSENS, P. P; LANDEWE, R. B. M; GARNERO, P et al.Arthritis and rheumatism. 2006, Vol 54, Num 6, pp 1772-1777, issn 0004-3591, 6 p.Article

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double bind randomised placebo controlled trialGERARDS, A. H; LANDEWE, R. B. M; PRINS, A. P. A et al.Annals of the rheumatic diseases. 2003, Vol 62, Num 4, pp 291-296, issn 0003-4967, 6 p.Article

Combination cyclosporine and (hydroxy) chloroquine in rheumatoid arthritisDIJKMANS, B. A. C; LANDEWE, R. B. M; VAN DEN BORNE, B. E. E. M et al.Clinical and experimental rheumatology (Testo stampato). 1999, Vol 17, Num 6, pp S.103-S.104, issn 0392-856X, SUP18Article

Cyclosporine and chloroquine synergistically inhibit the interferon-γ production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritisLANDEWE, R. B. M; MILTENBURG, A. M. M; BREEDVELD, F. C et al.Journal of rheumatology. 1992, Vol 19, Num 9, pp 1353-1357, issn 0315-162XArticle

Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis : a longitudinal analysisLANDEWE, R. B. M; GEUSENS, P; VAN DER HEIJDE, D. M. F. M et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 1, pp 40-44, issn 0003-4967, 5 p.Article

Spondylarthropathies: options for combination therapyVAN TUBERGEN, A. M; LANDEWE, R. B. M; VAN DER LINDEN, Sjef et al.Springer seminars in immunopathology. 2001, Vol 23, Num 1-2, pp 147-163, issn 0344-4325Article

Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidityLANDEWE, R. B. M; VAN DEN BORNE, B. E. E. M; BREEDVELD, F. C et al.Lancet (British edition). 2000, Vol 355, Num 9215, pp 1616-1617, issn 0140-6736Article

Chylothorax or leakage of total parenteral nutrition?WOLTHUIS, A; LANDEWE, R. B. M; THEUNISSEN, P. H. M. H et al.The European respiratory journal. 1998, Vol 12, Num 5, pp 1233-1235, issn 0903-1936Article

Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsivenessLANDEWE, R. B. M; MILTENBURG, A. M. M; VERDONK, M. J. A et al.Clinical and experimental immunology (Print). 1995, Vol 102, Num 1, pp 144-151, issn 0009-9104Article

Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritisVAN DEN BORNE, B. E. E. M; LANDEWE, R. B. M; GOEI THE, H. S et al.British journal of clinical pharmacology. 1995, Vol 39, Num 2, pp 172-175, issn 0306-5251Article

A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritisLANDEWE, R. B. M; GOEI THE, H. S; VAN RIJTHOVEN, A. W. A. M et al.Arthritis and rheumatism. 1994, Vol 37, Num 5, pp 637-643, issn 0004-3591Article